The current state of treatment of adverse reactions to injectable fillers

Dermatologic Surgery

Volumn 36, Issue SUPPL. 3, 2010, Pages 1895-1904

  Sperling, Berit ^a   Bachmann, Frank ^a   Hartmann, Vanessa ^a   Erdmann, Ricardo ^a   Wiest, Luitgard ^b   Rzany, Berthold ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Private Practice   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYETHYL METHACRYLATE; ALLOPURINOL; ANTIBIOTIC AGENT; FILLER; FLUOROURACIL; HYALURONIC ACID; METHOTREXATE; POLY(METHYL METHACRYLATE); POLYACRYLAMIDE; POLYLACTIC ACID; PREDNISOLONE; SILICON; STEROID; TACROLIMUS;

ADRENAL CORTEX DISEASE; ADRENOCORTICAL OBESITY; ADULT; ARTICLE; BIODEGRADABLE IMPLANT; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; EDEMA; ESTHETIC SURGERY; FEMALE; GRANULOMA; HEADACHE; HUMAN; HYPERTENSION; INJECTION SITE ABSCESS; INJECTION SITE REACTION; INTERVIEW; OUTCOME ASSESSMENT; PARESTHESIA; PRIORITY JOURNAL; SAFETY; SCAR FORMATION; SKIN ATROPHY; TREATMENT DURATION; TREATMENT OUTCOME;

DRUG TOXICITY; FEMALE; FOLLOW-UP STUDIES; GERMANY; HUMANS; INCIDENCE; INJECTIONS; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RHYTIDOPLASTY; SEVERITY OF ILLNESS INDEX; SKIN AGING; VISCOSUPPLEMENTS;

EID: 78349240644     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2010.01782.x     Document Type: Article

References (44)

1. Alcalay J, Alkalay R, Gat A, et al,. Late-onset granulomatous reaction to Artecoll. Dermatol Surg 2003; 29: 859-62.
2. Bardazzi F, Ruffato A, Antonucci A, et al,. Cutaneous granulomatous reaction to injectable hyaluronic acid gel: another case. J Dermatol Treat 2007; 18: 59-62.
3. Baumann LS, Kerdel F., The treatment of bovine collagen allergy with cyclosporin. Dermatol Surg 1999; 25: 247-9.
4. Becker-Wegerich P., [New indications for hyaluronic acid of the NASHA-gel-generation-highlights from aesthetical dermatology in clinical daily routine]. J Dtsch Dermatol Ges 2008; 6 (Suppl 3): S3-20.
5. Beljaards RC, De Roos KP, Bruins FG., NewFill for skin augmentation: a new filler or failure? Dermatol Surg 2005; 31: 772-6; discussion 76.
6. Brody HJ., Use of hyaluronidase in the treatment of granulomatous hyaluronic acid reactions or unwanted hyaluronic acid misplacement. Dermatol Surg 2005; 31: 893-7.
7. Christensen L, Breiting V, Vuuste J, et al,. Adverse reactions following injection with a permanent facial filler polyacrylamide hydrogel (Aquamid): causes and treatment. Eur J Plast Surg 2006; 28: 464-71.
8. Conejo-Mir JS, Sanz Guirado S, Angel Munoz M., Adverse granulomatous reaction to Artecoll treated by intralesional 5-fluorouracil and triamcinolone injections. Dermatol Surg 2006; 32: 1079-81; discussion 82.
9. De Boulle K., Management of complications after implantation of fillers. J Cosmet Dermatol 2004; 3: 2-15.
10. Ficarra G, Mosqueda-Taylor A, Carlos R., Silicone granuloma of the facial tissues: a report of seven cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002; 94: 65-73.
11. Lupton JR, Alster TS., Cutaneous hypersensitivity reaction to injectable hyaluronic acid gel. Dermatol Surg 2000; 26: 135-7.
12. Kim KJ, Lee HW, Lee MW, et al,. Artecoll granuloma: a rare adverse reaction induced by microimplant in the treatment of neck wrinkles. Dermatol Surg 2004; 30: 545-7.
13. Moody BR, Sengelmann RD., Topical tacrolimus in the treatment of bovine collagen hypersensitivity. Dermatol Surg 2001; 27: 789-91.
14. Shafir R, Amir A, Gur E., Long-term complications of facial injections with Restylane (injectable hyaluronic acid). Plast Reconstr Surg 2000; 106: 1215-6.
15. Sidwell RU, Dhillon AP, Butler PE, et al,. Localized granulomatous reaction to a semi-permanent hyaluronic acid and acrylic hydrogel cosmetic filler. Clin Exp Dermatol 2004; 29: 630-2.
16. Soparkar CN, Patrinely JR., Managing inflammatory reaction to Restylane. Ophthal Plast Reconstr Surg 2005; 21: 151-3.
17. Vargas-Machuca I, Gonzalez-Guerra E, Angulo J, et al,. Facial granulomas secondary to Dermalive microimplants: report of a case with histopathologic differential diagnosis among the granulomas secondary to different injectable permanent filler materials. Am J Dermatopathol 2006; 28: 173-7.
18. Waris PM, Lassila K, Tarm P, Konttinen YT., Alloplastic injectable biomaterials for soft tissue augmentation: a report on two cases with complications associated with a new material (Dermalive) and a review of the literature. Eur J Plast Surg 2003; 26: 350-5.
19. Wolfram D, Tzankov A, Piza-Katzer H., Surgery for foreign body reactions due to injectable fillers. Dermatology 2006; 213: 300-4.
20. Cheng NX, Xu SL, Deng H, et al,. Migration of implants: a problem with injectable polyacrylamide gel in aesthetic plastic surgery. Aesthet Plast Surg 2006; 30: 215-25.
21. Douse-Dean T, Jacob CI., Fast and easy treatment for reduction of the Tyndall effect secondary to cosmetic use of hyaluronic acid. J Drugs Dermatol 2008; 7: 281-3.
22. Ghislanzoni M, Bianchi F, Barbareschi M, et al,. Cutaneous granulomatous reaction to injectable hyaluronic acid gel. Br J Dermatol 2006; 154: 755-8.
23. Heise H, Zimmermann R, Heise P., Temporary granulomatous inflammation following collagen implantation. J Craniomaxillofac Surg 2001; 29: 238-41.
24. Honig JF, Brink U, Korabiowska M., Severe granulomatous allergic tissue reaction after hyaluronic acid injection in the treatment of facial lines and its surgical correction. J Craniofac Surg 2003; 14: 197-200.
25. Reisberger EM, Landthaler M, Wiest L, et al,. Foreign body granulomas caused by polymethylmethacrylate microspheres: successful treatment with allopurinol. Arch Dermatol 2003; 139: 17-20.
26. Zielke H, Wolber L, Wiest L, et al,. Risk profiles of different injectable fillers: results from the Injectable Filler Safety Study (IFS Study). Dermatol Surg 2008; 34: 326-35; discussion 35.
27. Roaner F, Roaner F, Kahl C, Rzany B., Klinisches Spektrum unerwünschter Reaktionen auf injizierbare Füllmaterialien: Fallberichte aus dem Berliner Register. Kosmetische Medizin 2006; 27: 4-8.
28. Rossner F, Rossner M, Hartmann V, et al,. Decrease of reported adverse events to injectable polylactic acid after recommending an increased dilution: 8-year results from the Injectable Filler Safety study. J Cosmet Dermatol 2009; 8: 14-8.
29. Rossner M, Rossner F, Bachmann F, et al,. Risk of severe adverse reactions to an injectable filler based on a fixed combination of hydroxyethylmethacrylate and ethylmethacrylate with hyaluronic acid. Dermatol Surg 2009; 35 (Suppl 1): 367-74.
30. Bachmann F, Erdmann R, Hartmann V, et al,. The spectrum of adverse reactions after treatment with injectable fillers in the glabellar region: results from the Injectable Filler Safety Study. Dermatol Surg 2009; 35 (Suppl 2): 1629-34.
31. Lemperle G, Rullan PP, Gauthier-Hazan N., Avoiding and treating dermal filler complications. Plast Reconstr Surg 2006; 118: 92S-107S. (Pubitemid 44319095)
32. Bergeret-Galley C, Latouche X, Illouz YG., The value of a new filler material in corrective and cosmetic surgery: DermaLive and DermaDeep. Aesthet Plast Surg 2001; 25: 249-55.
33. Cohen JL., Understanding, avoiding, and managing dermal filler complications. Dermatol Surg 2008; 34 (Suppl 1): S92-9.
34. Lemperle G, Gauthier-Hazan N., Foreign body granulomas after all injectable dermal fillers: part 2. Treatment options. Plast Reconstr Surgy 2009; 123: 1864-73.
35. Christensen L., Adverse reactions to injectable soft tissue permanent fillers. Aesthet Plast Surg 2005; 29: 34-48.
36. Lemperle G, Romano JJ, Busso M., Soft tissue augmentation with artecoll: 10-year history, indications, techniques, and complications. Dermatol Surg 2003; 29: 573-87; discussion 87.
37. Nicolau PJ., Long-lasting and permanent fillers: biomaterial influence over host tissue response. Plast Reconstr Surg 2007; 119: 2271-86.
38. Pons-Guiraud A., Actualisation des effects secondaires des produits de complement des rides. Nouv Dermatol 2003; 22: 205.
39. Wiest LG, Stolz W, Schroeder JA., Electron microscopic documentation of late changes in permanent fillers and clinical management of granulomas in affected patients. Dermatol Surg 2009; 35 (Suppl 2): 1681-8.
40. Lowe NJ, Maxwell CA, Patnaik R., Adverse reactions to dermal fillers: review. Dermatol Surg 2005; 31: 1616-25.
41. Bjarnsholt T, Tolker-Nielsen T, Givskov M, et al,. Detection of bacteria by fluorescence in situ hybridization in culture-negative soft tissue filler lesions. Dermatol Surg 2009; 35 (Suppl 2): 1620-4.
42. Bekersky I, Fitzsimmons W, Tanase A, et al,. Nonclinical and early clinical development of tacrolimus ointment for the treatment of atopic dermatitis. J Am Acad Dermatol 2001; 44: S17-27.
43. Bergeret-Galley C., Comparison of resorbable soft tissue fillers. Aesthet Surg J 2004; 24: 33-46.
44. Cassuto D, Marangoni O, De Santis G, et al,. Advanced laser techniques for filler-induced complications. Dermatol Surg 2009; 35 (Suppl 2): 1689-95.